GLOBAL MED TECHNOLOGIES INC
EXHIBIT 10.1
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>gbl33110qex10.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>

<HTML>
<HEAD>
<TITLE>Exhibit 10.1--3/31/01 10-Q</TITLE>
</HEAD>
<BODY>


<H1 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>Exhibit 10.1</U></FONT></H1>

<BR>
<BR>
<BR>


<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>INTEREST
PAYMENT OPTION</FONT></H1>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>This Interest Payment
Option (&#147;Option&#148;) dated this 21st day of March, 2001, is offered by
eBANKER USA.COM, INC., a Colorado corporation (&#147;eBanker&#148;) having an
address of 1700 Lincoln Street, 31st Floor, Denver, Colorado 80203 to GLOBAL MED
TECHNOLOGIES, INC., a Colorado corporation (&#147;Global&#148; or
&#147;Borrower&#148;) having an address of 12600 West Colfax Avenue, Suite A500,
Lakewood, Colorado 80215 (collectively the &#147;Parties&#148;). </FONT></P>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>WHEREAS, </B>the Parties
entered into a Loan Restructuring and Restatement Agreement
(&#147;Agreement&#148;) dated November 19, 2000, and; </FONT></P>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>WHEREAS, </B> pursuant
to  the  Agreement,  Global  agreed  to  pay  interest  of 12%  per  annum  on a
semi-annual basis, with the first interest payment due May 19, 2001;</FONT></P>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>eBanker wishes to offer
an option to Global regarding  Global's interest payments to eBanker pursuant to
the agreement as follows:</FONT></P>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%>&nbsp;</TD>
<TD WIDTH=95%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
eBanker
agrees that Global may have the option, with five days prior written notice, to
elect and pay to eBanker, before July 1, 2001, Global&#146;s entire interest
payment calculated for the life of Agreement, in the form of 1,746,688 shares of
Global common stock (calculated at $0.6875 per share, which is prevailing market
price of March 22, 2001).</FONT></TD>
</TR>
</TABLE>
<BR>
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
<TR VALIGN=TOP>
<TD WIDTH=5%>&nbsp;</TD>
<TD WIDTH=95%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
In
the event that Global pays down any principal on the loan prior to July 1, 2003,
eBanker will return a number of shares determined by calculating the pro-rata
interest avoided due to early repayment of principal divided by $0.6875 per
share. eBanker will make this calculation on July 1, 2001, July 1, 2002 and July
1, 2003.</FONT></TD>
</TR>
</TABLE>
<BR>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Agreed to as of the date
first above written:</FONT></P>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>GLOBAL MED
TECHNOLOGIES, INC.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
eBANKER USA.COM, INC.</B><BR>
<BR>
<U>/s/  Michael I. Ruxin</U>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;
<U>/s/  Robert H. Trapp</U><BR>
Dr. Michael I. Ruxin
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;Robert H. Trapp<BR>
Chairman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
